Hyper-CVAD therapy is superior to our previous regimens and should be compared with established regimens in adult ALL.
No takes yet. Share an insight, caveat, or question.
Kantarjian et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: